The premier issue highlights the fundamentals of biosimilar regulation and development in the US and recently released materials on biosimilars, Dr. Edward Li.

An 11-Minute Tutorial:
Dr. Edward Li discusses the fundamentals of “Biosimilar Regulation and Development in the US"

Listen to Dr. Li describe the similarities and differences between biosimilars and reference biologics, and review current FDA regulation guidance



biosimilars survey  
Survey Question:
On a scale of 1 to 100, if approved by the FDA, what is your interest in prescribing, dispensing or administering biosimilars in your practice setting?


Request a Live Meeting

Support available for Grand Rounds, Chapter Meetings, and other gatherings.

New & Noteworthy